CDK2-IN-41

CAT: 0804-HY-172153Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-172153Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
CDK2-IN-41 (Compound 7a) is a CDK2 inhibitor that exerts anticancer activity by binding to CDK2, thereby inhibiting the cell cycle, inducing cytotoxicity, promoting ROS production, and triggering Apoptosis. CDK2-IN-41 exhibits an IC50 of 10 µM against acute myeloid leukemia (AML) HL-60 cells. It holds potential for research in AML-related cancer therapy[1].
UNSPSC
12352005
Target
Apoptosis; CDK; Reactive Oxygen Species (ROS)
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Field of Research
Cancer
Smiles
N#CC1=C2C(CNCC2)=C(C=C1N3CCCCC3)C4=CC=CS4
Molecular Formula
C19H21N3S
Molecular Weight
323.46
References & Citations
[1]Ananta, et al. Design, Synthesis, and Simulation of Functionalized 1, 2, 3, 4‐Tetrahydroisoquinolines to Treat Acute Leukemia Cells[J]. ChemistrySelect, 2025, 10 (7) : e202404024.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK2

Related Products

CatalogName
HY-147794-01CDK9-IN-41
HY-P0235CDK2
HY-134622-01GSK-3/CDK5/CDK2-IN-1
HY-179231CDK2-IN-50
HY-178756CDK2-IN-48
HY-173310CDK2-IN-44
HY-173203CDK2-IN-43
HY-170441CDK2-IN-36
HY-169683CDK2-IN-39
HY-160185CDK2-IN-21

Alternative Products

CatalogName
T205333-01CDK2-IN-41
C07088-01CDK2-IN-73 (CDK2-IN-4)
MBS8534571-01CDK2
MBS851823-01CDK2 Antibody
505651-01CDK2 discontinued
117168Human CDK2

Popular Products